Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.
Conditions:
🦠 HIV Infections
🗓️ Study Start (Actual) 9 February 2024
🗓️ Primary Completion (Estimated) 30 April 2025
✅ Study Completion (Estimated) 30 April 2025
👥 Enrollment (Estimated) 1000
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Los Angeles, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Have access to a personal smartphone device;
    • * Over 18 years of age;
    • * Speak English or Spanish;
    • * Living with HIV
    • * Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;
    • * Active substance use or mental health disorder;
    • * Willing and able to provide written informed consent to take part in the study.

    Exclusion Criteria:

    • * Unwilling or unable to provide reliable contact information;
    • * Unwilling to provide blood sample for HIV virology testing;
    • * Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 10 April 2024
  • First Submitted that Met QC Criteria 12 April 2024
  • First Posted 17 April 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 11 June 2024
  • Last Update Posted 13 June 2024
  • Last Verified June 2024